Supernus Pharmaceuticals, Inc. (SUPN)

NASDAQ: SUPN · Real-Time Price · USD

42.07

+0.86 (2.09%)

At close: Oct 22, 2026, 4:00 PM EDT

42.65

+0.58 (1.38%)

Pre-market: Oct 23, 2026, 5:33 AM EDT

Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	2,445	2,850	1,997	1,581	1,928	1,551
Market Cap Growth	-13.93%	42.72%	26.29%	-18.00%	24.34%	16.99%
Enterprise Value	2,114	2,611	1,632	1,398	1,849	1,128
Last Close Price	42.07	49.70	36.16	28.94	35.67	29.16

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	27.03	1201.42	31.76	29.03
Forward PE	11.92	19.33	19.65	15.34	30.84	15.73
PS Ratio	2.94	3.96	3.02	2.60	2.89	2.68
PB Ratio	2.37	2.68	1.93	1.72	2.18	1.90
P/TBV Ratio	5.53	7.76	5.03	7.73	28.90	-
P/FCF Ratio	130.16	61.96	11.66	14.30	16.56	12.40
P/OCF Ratio	122.82	60.21	11.61	14.23	16.51	12.20
PEG Ratio	0.63	0.51	1.11	1.11	1.11	1.11

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.55	3.63	2.47	2.30	2.77	1.95
EV/EBITDA Ratio	19.14	22.25	11.51	14.23	14.10	10.06
EV/EBIT Ratio	242.07	101.35	26.59	104.31	40.53	14.18
EV/FCF Ratio	112.50	56.77	9.53	12.65	15.88	9.01

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.04	0.04	0.03	0.05	0.51	0.54
Debt / EBITDA Ratio	0.32	0.31	0.22	0.37	3.13	3.55
Debt / FCF Ratio	2.14	0.89	0.20	0.38	3.87	3.52
Net Debt / Equity Ratio	-0.32	-0.25	-0.40	-0.25	-0.12	-0.02
Net Debt / EBITDA Ratio	-3.00	-2.28	-2.96	-2.34	-0.80	-0.17
Net Debt / FCF Ratio	-17.67	-5.82	-2.45	-2.08	-0.90	-0.15
Asset Turnover	0.59	0.51	0.50	0.41	0.39	0.36
Inventory Turnover	3.52	2.65	2.84	2.08	0.98	1.12
Quick Ratio	1.68	1.47	2.04	1.38	0.91	1.55
Current Ratio	2.08	1.91	2.35	1.70	1.07	1.91
Return on Equity (ROE)	-10.49%	-3.68%	7.55%	0.15%	7.13%	6.85%
Return on Assets (ROA)	0.39%	1.14%	2.90%	0.56%	1.68%	3.11%
Return on Invested Capital (ROIC)	1.22%	3.65%	6.99%	0.80%	5.09%	6.93%
Return on Capital Employed (ROCE)	0.80%	2.30%	5.70%	1.40%	4.50%	5.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-4.55%	-1.35%	3.70%	0.08%	3.15%	3.45%
FCF Yield	0.77%	1.61%	8.58%	6.99%	6.04%	8.07%
Buyback Yield / Dilution	-1.67%	-0.88%	-0.81%	10.01%	-13.47%	-1.24%

SEC Filings: 10-K · 10-Q